Ryan Pruchnic
Direktor/Vorstandsmitglied bei LIPELLA PHARMACEUTICALS INC.
Vermögen: - $ am 30.04.2024
Profil
Ryan Pruchnic has worked as an Independent Director at Lipella Pharmaceuticals, Inc. since 2021 and as a Managing Vice President at Cook MyoSite, Inc. since 2001.
He has an undergraduate and graduate degree from the University of Pittsburgh.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Ryan Pruchnic
Unternehmen | Position | Beginn |
---|---|---|
LIPELLA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.09.2021 |
Cook MyoSite, Inc.
Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Ryan Pruchnic
University of Pittsburgh | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LIPELLA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cook MyoSite, Inc.
Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Technology Services |